U.S. flag

An official website of the United States government

NM_033337.3(CAV3):c.80G>A (p.Arg27Gln) AND Rippling muscle disease 2

Germline classification:
Pathogenic (3 submissions)
Last evaluated:
Aug 26, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000008778.12

Allele description [Variation Report for NM_033337.3(CAV3):c.80G>A (p.Arg27Gln)]

NM_033337.3(CAV3):c.80G>A (p.Arg27Gln)

Genes:
SSUH2:ssu-2 homolog [Gene - OMIM - HGNC]
CAV3:caveolin 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p25.3
Genomic location:
Preferred name:
NM_033337.3(CAV3):c.80G>A (p.Arg27Gln)
Other names:
NM_001234.4(CAV3):c.80G>A(p.Arg27Gln); NM_033337.2(CAV3):c.80G>A(p.Arg27Gln)
HGVS:
  • NC_000003.12:g.8733956G>A
  • NG_008797.2:g.5147G>A
  • NM_001234.5:c.80G>A
  • NM_033337.3:c.80G>AMANE SELECT
  • NP_001225.1:p.Arg27Gln
  • NP_203123.1:p.Arg27Gln
  • NP_203123.1:p.Arg27Gln
  • LRG_329t1:c.80G>A
  • LRG_329:g.5147G>A
  • LRG_329p1:p.Arg27Gln
  • NC_000003.11:g.8775642G>A
  • NM_033337.1:c.80G>A
  • NM_033337.2:c.80G>A
  • NM_033337.3:c.80G>A
  • P56539:p.Arg27Gln
  • p.(Arg27Gln)
  • r.80g>a
Protein change:
R27Q; ARG27GLN
Links:
Leiden Muscular Dystrophy (CAV3): CAV3_00007; UniProtKB: P56539#VAR_011512; OMIM: 601253.0007; dbSNP: rs116840778
NCBI 1000 Genomes Browser:
rs116840778
Molecular consequence:
  • NM_001234.5:c.80G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033337.3:c.80G>A - missense variant - [Sequence Ontology: SO:0001583]
Functional consequence:
functional variant [Sequence Ontology: SO:0001536]
Observations:
1

Condition(s)

Name:
Rippling muscle disease 2 (RMD2)
Synonyms:
Limb-girdle muscular dystrophy, type 1C; CAV3-Related Rippling Muscle Disease
Identifiers:
MONDO: MONDO:0019947; MedGen: C1832560; Orphanet: 265; OMIM: 606072

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000028985OMIM
no assertion criteria provided
Pathogenic
(Jan 15, 2009)
germlineliterature only

PubMed (9)
[See all records that cite these PMIDs]

SCV000803482SIB Swiss Institute of Bioinformatics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(May 31, 2018)
unknowncuration

PubMed (5)
[See all records that cite these PMIDs]

SCV002581137MGZ Medical Genetics Center
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Aug 26, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot providednot providednot providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedunknownunknownnot providednot providednot providednot providednot providedcuration

Citations

PubMed

Phenotypic variability in rippling muscle disease.

Vorgerd M, Bolz H, Patzold T, Kubisch C, Malin JP, Mortier W.

Neurology. 1999 Apr 22;52(7):1453-9.

PubMed [citation]
PMID:
10227634

Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease.

Betz RC, Schoser BG, Kasper D, Ricker K, Ramírez A, Stein V, Torbergsen T, Lee YA, Nöthen MM, Wienker TF, Malin JP, Propping P, Reis A, Mortier W, Jentsch TJ, Vorgerd M, Kubisch C.

Nat Genet. 2001 Jul;28(3):218-9.

PubMed [citation]
PMID:
11431690
See all PubMed Citations (10)

Details of each submission

From OMIM, SCV000028985.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (9)

Description

The numbering of this CAV3 mutation (R27Q) is based on the numbering system used by Fulizio et al. (2005). Early reports designated this mutation ARG26GLN.

In kindred B with autosomal dominant rippling muscle disease (RMD2; 606072) described by Vorgerd et al. (1999), Betz et al. (2001) identified an arg26-to-gln (R26Q) substitution in the CAV3 gene.

In a patient with sporadic rippling muscle disease, Vorgerd et al. (2001) identified a heterozygous R26Q mutation in exon 1 of the CAV3 gene, which was not found in either parent. Muscle biopsy of the patient showed reduced sarcolemmal caveolin-3 with punctated cytosolic staining, consistent with intracellular retention of an unstable protein. Neuronal nitric oxide synthase (nNOS) expression was normal. Vorgerd et al. (2001) suggested that increased inducibility of nNOS, caused by lack of inhibition by normal caveolin, may contribute to muscle hyperexcitability in rippling muscle disease.

In a 71-year-old woman with a diagnosis of limb-girdle muscular dystrophy (LGMD1C), which was reclassified by Straub et al. (2018) as rippling muscle disease (RMD2; 606072), Figarella-Branger et al. (2003) identified a heterozygous R26Q mutation, which they referred to as ARG27GLN. Muscle biopsy showed fibers of various sizes, centrally located nuclei, occasional necrotic and regenerative fibers, decreased dysferlin immunoreactivity, and near absence of caveolin-3. Although this was a late presentation, the authors could not rule out a very slow but myopathic evolution of a putative hyperCKemia in infancy. Figarella-Branger et al. (2003) emphasized the heterogeneous clinical phenotypes that had been reported in association with this CAV3 mutation.

Carbone et al. (2000) identified a de novo recurrent sporadic mutation, R26Q, in the CAV3 gene in 2 unrelated children with persistent elevated levels of serum creatine kinase (hyperCKemia; 123320) without muscle weakness. Immunohistochemistry and quantitative immunoblot analysis of caveolin-3 showed reduced expression of the protein in muscle fibers. Carbone et al. (2000) concluded that partial caveolin-3 deficiency should be considered in the differential diagnosis of idiopathic hyperCKemia.

In a Japanese woman with a relatively mild nonspecific sporadic distal myopathy (MPDT; 614321), Tateyama et al. (2002) identified the R26Q mutation. Muscle atrophy and weakness was limited to the small muscles of the hands and feet. She also showed increased creatine kinase, myopathic changes on biopsy and EMG, and decreased caveolin-3 and dysferlin (603009) immunoreactivity. Tateyama et al. (2002) noted the unusual clinical phenotype of the patient.

Gonzalez-Perez et al. (2009) identified the R27Q mutation in a Spanish family with autosomal dominant inheritance of distal myopathy and increased serum creatine kinase. The proband was a 77-year-old man who had onset in his mid-forties of distal muscle weakness and atrophy, particularly affecting the thenar and hypothenar muscles in both hands, as well as the intrinsic finger muscles. Other features included calf hypertrophy, pes cavus, and percussion-induced rapid contractions, predominantly in distal muscles of upper limbs. He had 4 affected sons, 3 of whom presented in their twenties with increased serum creatine kinase, calf hypertrophy, and pes cavus; 1 had percussion-induced rapid contractions. All later developed distal muscle weakness and atrophy affecting the hands. The fourth son, aged 33 years, had increased serum creatine kinase and pes cavus, but no evidence of motor deficit. Two granddaughters of the proband had pes cavus and increased serum creatine kinase, but no motor deficit. One had percussion-induced rapid contractions and the other had myalgias. Muscle biopsy of the proband showed slight variation in fiber size and increased number of internal nuclei, but no dystrophic changes. Caveolin-3 expression was greatly reduced in the sarcolemma, and there was a moderate reduction of dysferlin immunolabeling. Electron microscopy revealed focal loss of sarcolemma, abnormal sarcolemmal folding, absence of normal caveolae, and enlarged subsarcolemmal space with large vacuoles. Gonzalez-Perez et al. (2009) noted the variable phenotypic features in this family.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From SIB Swiss Institute of Bioinformatics, SCV000803482.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (5)

Description

This variant is interpreted as a Pathogenic, for Caveolinopathies (creatine phosphokinase, elevated serum. HyperCKemia. Rippling muscle disease 2 (RMD2). Myopathy, distal, Tateyama type (MPDT). Limb-girdle muscular dystrophy 1C (LGMD1C)), in Autosomal Dominant manner. The following ACMG Tag(s) were applied: PP3 => Multiple lines of computational evidence support a deleterious effect on the gene or gene product. PM6 => Assumed de novo, but without confirmation of paternity and maternity (PMID:10746614). PS2 => De novo (paternity and maternity confirmed) (PMID:11756609). PS3 => Well-established functional studies show a deleterious effect (PMID:12939441) (PMID:15580566). PM2 => Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PS4-Moderate => PS4 downgraded in strength to Moderate.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From MGZ Medical Genetics Center, SCV002581137.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Jul 15, 2024